E
Cano Health, Inc.
CANOQ
OTC PK
E
Sell
1/30/2024Downgrade
Cano Health, Inc. (CANO) was downgraded to E from E+ on 1/30/2024 due to a decline in the volatility index and total return index.
Cano Health, Inc. (CANO) was downgraded to E from E+ on 1/30/2024 due to a decline in the volatility index and total return index.
E
Sell
11/14/2023Downgrade
Cano Health, Inc. (CANO) was downgraded to E+ from D- on 11/14/2023 due to a major decline in the solvency index, volatility index and total return index. The quick ratio declined from 0.4 to 0.35.
Cano Health, Inc. (CANO) was downgraded to E+ from D- on 11/14/2023 due to a major decline in the solvency index, volatility index and total return index. The quick ratio declined from 0.4 to 0.35.
D
Sell
11/3/2023Upgraded
Cano Health, Inc. (CANO) was upgraded to D- from E+ on 11/3/2023 due to an increase in the volatility index, total return index and valuation index.
Cano Health, Inc. (CANO) was upgraded to D- from E+ on 11/3/2023 due to an increase in the volatility index, total return index and valuation index.
E
Sell
3/16/2023Downgrade
Cano Health, Inc. (CANO) was downgraded to E+ from D on 3/16/2023 due to a significant decline in the efficiency index, solvency index and growth index. Operating cash flow declined 3,032.44% from -$1.99M to -$62.18M, net income declined 173.61% from -$54.23M to -$148.37M, and earnings per share declined from -$0.2334 to -$0.6153.
Cano Health, Inc. (CANO) was downgraded to E+ from D on 3/16/2023 due to a significant decline in the efficiency index, solvency index and growth index. Operating cash flow declined 3,032.44% from -$1.99M to -$62.18M, net income declined 173.61% from -$54.23M to -$148.37M, and earnings per share declined from -$0.2334 to -$0.6153.
D
Sell
5/10/2022Upgraded
Cano Health, Inc. (CANO) was upgraded to D from D- on 5/10/2022 due to a significant increase in the efficiency index, growth index and solvency index. Net income increased 105.12% from -$12.9M to $660, earnings per share increased from -$0.6791 to -$0.0002, and EBIT increased 89.86% from -$76.36M to -$7.74M.
Cano Health, Inc. (CANO) was upgraded to D from D- on 5/10/2022 due to a significant increase in the efficiency index, growth index and solvency index. Net income increased 105.12% from -$12.9M to $660, earnings per share increased from -$0.6791 to -$0.0002, and EBIT increased 89.86% from -$76.36M to -$7.74M.
D
Sell
5/5/2022Upgraded
Cano Health, Inc. (CANOQ) was upgraded to D- from E+ on 05/05/2022.
Cano Health, Inc. (CANOQ) was upgraded to D- from E+ on 05/05/2022.
E
Sell
4/20/2022Downgrade
Cano Health, Inc. (CANO) was downgraded to E+ from D- on 4/20/2022 due to a decline in the total return index, growth index and volatility index. EBIT declined 788.57% from -$13.58M to -$120.62M, earnings per share declined from -$0.09 to -$0.6791, and total revenue declined 22.31% from $526.8M to $409.27M.
Cano Health, Inc. (CANO) was downgraded to E+ from D- on 4/20/2022 due to a decline in the total return index, growth index and volatility index. EBIT declined 788.57% from -$13.58M to -$120.62M, earnings per share declined from -$0.09 to -$0.6791, and total revenue declined 22.31% from $526.8M to $409.27M.
D
Sell
2/28/2022Downgrade
Cano Health, Inc. (CANO) was downgraded to D- from D on 2/28/2022 due to a substantial decline in the total return index and volatility index.
Cano Health, Inc. (CANO) was downgraded to D- from D on 2/28/2022 due to a substantial decline in the total return index and volatility index.
D
Sell
11/15/2021Downgrade
Cano Health, Inc. (CANO) was downgraded to D from D+ on 11/15/2021 due to a significant decline in the efficiency index, growth index and solvency index. EBIT declined 545.67% from $3.05M to -$13.58M, net income declined 254.4% from $9.48M to -$14.64M, and earnings per share declined from -$0.0268 to -$0.09.
Cano Health, Inc. (CANO) was downgraded to D from D+ on 11/15/2021 due to a significant decline in the efficiency index, growth index and solvency index. EBIT declined 545.67% from $3.05M to -$13.58M, net income declined 254.4% from $9.48M to -$14.64M, and earnings per share declined from -$0.0268 to -$0.09.
D
Sell
11/9/2021Upgraded
Cano Health, Inc. (CANO) was upgraded to D+ from D on 11/9/2021 due to a significant increase in the total return index, volatility index and solvency index.
Cano Health, Inc. (CANO) was upgraded to D+ from D on 11/9/2021 due to a significant increase in the total return index, volatility index and solvency index.
D
Sell
8/27/2021None
Cano Health, Inc. (CANOQ) was downgraded to D from U on 08/27/2021.
Cano Health, Inc. (CANOQ) was downgraded to D from U on 08/27/2021.
